共 50 条
Efficacy and Safety of Omalizumab in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial
被引:0
|作者:
Casale, Thomas
[1
]
Maurer, Marcus
[2
]
Hsieh, Hsin-Ju
[3
]
Canvin, Janice
[4
]
Saini, Sarbjit S.
[5
]
Grattan, Clive
[6
]
Gimenez-Arnau, Ana
[7
]
Kaplan, Allen P.
[8
]
Rosen, Karin
[3
]
机构:
[1] Creighton Univ, Med Ctr, Omaha, NE USA
[2] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Novartis Pharmaceut UK Ltd, Horsham, W Sussex, England
[5] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA
[6] Norfolk & Norwich Univ Hosp, Dept Dermatol, Norwich, Norfolk, England
[7] Univ Autonoma Barcelona, Hosp Mar, Dept Dermatol, E-08193 Barcelona, Spain
[8] Med Univ S Carolina, Charleston, SC 29425 USA
关键词:
D O I:
10.1016/j.jaci.2012.12.1546
中图分类号:
R392 [医学免疫学];
学科分类号:
100102 ;
摘要:
引用
收藏
页码:AB327 / AB327
页数:1
相关论文